Insiders · PSTV

PSTV insider transactions

PLUS THERAPEUTICS Inc. (PSTV) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PSTV

• 20d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 20d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 20d
  SEC Form 4 filed by Director Guse Kyle

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 20d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 20d
  SEC Form 4 filed by Director Andrews Ronald Asbury

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 20d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 20d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 46d
  SEC Form 4 filed by Daniels Eric Joseph

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 47d
  SEC Form 3 filed by new insider Daniels Eric Joseph

  3 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 67d
  SEC Form 4 filed by Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 67d
  SEC Form 4 filed by Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 69d
  SEC Form 3 filed by new insider Andrews Ronald Asbury

  3 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 100d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 100d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 156d
  Chief Executive Officer Hedrick Marc H converted options into 159,681 shares, increasing direct ownership by 89% to 339,787 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 156d
  Chief Financial Officer Sims Andrew John Hugh Macintyre converted options into 38,323 shares, increasing direct ownership by 56% to 106,461 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 214d
  Chief Financial Officer Sims Andrew John Hugh Macintyre bought $10,200 worth of shares (20,000 units at $0.51), increasing direct ownership by 42% to 68,138 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 247d
  Chief Executive Officer Hedrick Marc H converted options into 159,681 shares, increasing direct ownership by 782% to 180,106 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 247d
  Amendment: SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4/A - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 247d
  Chief Financial Officer Sims Andrew John Hugh Macintyre converted options into 38,323 shares, increasing direct ownership by 390% to 48,138 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 247d
  Amendment: SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4/A - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 286d
  Director Lenk Robert P bought $53,779 worth of shares (110,000 units at $0.49), increasing direct ownership by 375% to 139,327 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  SEC Form 4 filed by Director Guse Kyle

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  SEC Form 4 filed by Director Lenk Robert P

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 296d
  New insider Guse Kyle claimed no ownership of stock in the company (SEC Form 3)

  3 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 472d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 472d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 472d
  SEC Form 4 filed by Director Petersen Greg

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 472d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 472d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 472d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 472d
  SEC Form 4 filed by Director Lenk Robert P

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 628d
  Director Hawkins Richard J bought $5,996 worth of shares (4,000 units at $1.50), increasing direct ownership by 36% to 15,188 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 629d
  Director Hawkins Richard J bought $8,512 worth of shares (6,285 units at $1.35), increasing direct ownership by 128% to 11,188 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  Director Petersen Greg bought $16,875 worth of shares (12,500 units at $1.35), increasing direct ownership by 34% to 48,921 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  Director Clowes Howard bought $6,681 worth of shares (5,000 units at $1.34), increasing direct ownership by 23% to 26,497 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  SEC Form 4 filed by Director Petersen Greg

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 633d
  SEC Form 4 filed by Director Lenk Robert P

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 635d
  Chief Executive Officer Hedrick Marc H bought $9,839 worth of shares (8,000 units at $1.23), increasing direct ownership by 64% to 20,425 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 635d
  Chief Financial Officer Sims Andrew John Hugh Macintyre bought $5,204 worth of shares (4,098 units at $1.27), increasing direct ownership by 72% to 9,815 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 758d
  Sims Andrew John Hugh Macintyre bought $10,000 worth of shares (4,902 units at $2.04), increasing direct ownership by 601% to 5,717 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 758d
  Hedrick Marc H bought $25,000 worth of shares (12,255 units at $2.04), increasing direct ownership by 7,209% to 12,425 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 758d
  Clowes Howard bought $20,000 worth of shares (9,804 units at $2.04), increasing direct ownership by 84% to 21,497 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 758d
  Petersen Greg bought $25,000 worth of shares (12,255 units at $2.04), increasing direct ownership by 51% to 36,421 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 758d
  Hawkins Richard J bought $10,000 worth of shares (4,902 units at $2.04), increasing direct ownership by 490,200% to 4,903 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 758d
  Lenk Robert P bought $8,501 worth of shares (4,167 units at $2.04), increasing direct ownership by 17% to 29,327 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 832d
  SEC Form 4 filed by Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 832d
  SEC Form 4 filed by Lafrance Norman D.

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 832d
  SEC Form 4 filed by Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 832d
  SEC Form 4 filed by Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)